Correlation Between GlaxoSmithKline PLC and Partner

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Partner at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Partner into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Partner, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Partner and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Partner. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Partner.

Diversification Opportunities for GlaxoSmithKline PLC and Partner

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GlaxoSmithKline and Partner is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Partner in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Partner and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Partner. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Partner has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Partner go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Partner

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 8.37 times less return on investment than Partner. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 2.01 times less risky than Partner. It trades about 0.02 of its potential returns per unit of risk. Partner is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  146,500  in Partner on August 31, 2024 and sell it today you would earn a total of  68,000  from holding Partner or generate 46.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy77.81%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Partner

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Partner 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Partner are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Partner sustained solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and Partner Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Partner

The main advantage of trading using opposite GlaxoSmithKline PLC and Partner positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Partner can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Partner will offset losses from the drop in Partner's long position.
The idea behind GlaxoSmithKline PLC ADR and Partner pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.